Skip to main content

Table 2 Patient preoperative status

From: Complications after radical gastrectomy following FOLFOX7 neoadjuvant chemotherapy for gastric cancer

 

NACT (%)

n = 110

SURG (%)

n = 267

P value

Body mass index (BMI)

22.92 ± 3.12

23.03 ± 3.56

0.773

White blood cells

5.29 ± 1.84

6.25 ± 2.10

0.000

Hemoglobin

121.72 ± 21.92

123.93 ± 28.26

0.417

Serum albumin

42.83 ± 4.25

42.18 ± 4.62

0.211

CEA

15.986 ± 67.377

4.357 ± 9.192

0.081

CA199

175.836 ± 803.631

81.270 ± 394.942

0.255

Comorbid illness

44(40.0%)

139(52.1%)

0.033

Cardiovascular

20(18.2%)

71(26.6%)

0.083

Pulmonary

3(2.7%)

9(3.4%)

1.000

Gastric Disease

1(0.9%)

12(4.5%)

0.119

Renal

0(0.0%)

5(1.9%)

0.327

Diabetes mellitus

6(5.5%)

28(10.5%)

0.121

Liver disease

3(2.7%)

10(3.7%)

0.764

Operation history

20(18.2%)

48(18.0%)

0.963

Tuberculosis history

1(0.9%)

3(1.1%)

1.000

Others

7(6.4%)

14(5.2%)

0.666